Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2011 1
2012 1
2013 1
2014 1
2015 6
2016 6
2017 11
2018 10
2019 7
2020 7
2021 11
2022 11
Text availability
Article attribute
Article type
Publication date

Search Results

65 results
Results by year
Filters applied: . Clear all
Page 1
Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trial.
de Bono JS, Mehra N, Scagliotti GV, Castro E, Dorff T, Stirling A, Stenzl A, Fleming MT, Higano CS, Saad F, Buttigliero C, van Oort IM, Laird AD, Mata M, Chen HC, Healy CG, Czibere A, Fizazi K. de Bono JS, et al. Among authors: buttigliero c. Lancet Oncol. 2021 Sep;22(9):1250-1264. doi: 10.1016/S1470-2045(21)00376-4. Epub 2021 Aug 10. Lancet Oncol. 2021. PMID: 34388386 Clinical Trial.
Hormonal treatment and quality of life of prostate cancer patients: new evidence.
Tucci M, Leone G, Buttigliero C, Zichi C, DI Stefano RF, Pignataro D, Vignani F, Scagliotti GV, DI Maio M. Tucci M, et al. Among authors: buttigliero c. Minerva Urol Nefrol. 2018 Apr;70(2):144-151. doi: 10.23736/S0393-2249.17.03066-1. Epub 2017 Dec 14. Minerva Urol Nefrol. 2018. PMID: 29241313 Free article. Review.
Bipolar androgen therapy in prostate cancer: Current evidences and future perspectives.
Leone G, Buttigliero C, Pisano C, Di Stefano RF, Tabbò F, Turco F, Vignani F, Scagliotti GV, Di Maio M, Tucci M. Leone G, et al. Among authors: buttigliero c. Crit Rev Oncol Hematol. 2020 Aug;152:102994. doi: 10.1016/j.critrevonc.2020.102994. Epub 2020 May 24. Crit Rev Oncol Hematol. 2020. PMID: 32480269 Review.
68Ga-PSMA Uptake in Fibrous Dysplasia.
Reale ML, Buttigliero C, Tucci M, Giardino R, Poti C. Reale ML, et al. Among authors: buttigliero c. Clin Nucl Med. 2019 Jun;44(6):e396-e397. doi: 10.1097/RLU.0000000000002546. Clin Nucl Med. 2019. PMID: 30932978
Darolutamide in Metastatic Prostate Cancer.
Turco F, Tucci M, Buttigliero C. Turco F, et al. Among authors: buttigliero c. N Engl J Med. 2022 Jun 16;386(24):2344. doi: 10.1056/NEJMc2205310. N Engl J Med. 2022. PMID: 35704492 No abstract available.
The prognostic value of pain in castration-sensitive prostate cancer.
Iacovelli R, Ciccarese C, Caffo O, De Giorgi U, Tucci M, Mosillo C, Bimbatti D, Pierantoni F, Maines F, Casadei C, Buttigliero C, Milella M, Tortora G. Iacovelli R, et al. Among authors: buttigliero c. Prostate Cancer Prostatic Dis. 2020 Dec;23(4):654-660. doi: 10.1038/s41391-020-0255-x. Epub 2020 Jul 10. Prostate Cancer Prostatic Dis. 2020. PMID: 32651468
65 results